Skip to main content
Home
FULL MENU Close Menu
Home
Home

Heidi Splete

News

FDA approves dupilumab for treatment of prurigo nodularis

Author:
Heidi Splete
Publish date: September 29, 2022

Approval was based on data from two randomized, controlled trials, PRIME and PRIME2, comparing dupilumab with placebo in 311 adults with...

  • Read More

News

Increasing primary care doctors’ knowledge of IPF could speed up diagnoses, suggests white paper

Author:
Heidi Splete
Publish date: September 28, 2022

Nonspecific symptoms of IPF may prompt primary care providers to pursue other assessment pathways.

  • Read More

News

Psoriasis, psoriatic arthritis insurance coverage remains restrictive

Author:
Heidi Splete
Publish date: September 26, 2022

A database review showed restrictive coverage of specialty medications for psoriatic disease beyond the label indications.

  • Read More

News

Corticosteroids found to curb progression in community-acquired pneumonia

Author:
Heidi Splete
Publish date: September 23, 2022

Patients with CAP were less likely to progress to mechanical ventilation after corticosteroid therapy.

  • Read More

News

Mindfulness eases asthma burden

Author:
Heidi Splete
Publish date: September 23, 2022

Asthma patients who practiced mindfulness experienced significant improvement in symptoms.

  • Read More

News

CRP levels could predict SSRI success

Author:
Heidi Splete
Publish date: September 23, 2022

SSRIs were less effective in depressed patients with high C-reactive protein levels than in those with low levels.

  • Read More

News

Community-level actions could mitigate maternal mortality

Author:
Heidi Splete
Publish date: September 21, 2022

National Institute for Health Care Management panelists advocate partnerships between hospitals and community centers to ease barriers to access...

  • Read More

News

Tralokinumab earns EU recommendation to expand age range for atopic dermatitis to include adolescents

Author:
Heidi Splete
Publish date: September 20, 2022

In December 2021, tralokinumab was approved for adults with moderate to severe AD in the United States, where it is marketed as Adbry.

  • Read More

News

Esophageal motility issues may promote respiratory disease

Author:
Heidi Splete
Publish date: September 19, 2022

High-resolution manometry showed increased dysmotility in patients with higher measures of airway reflux.

  • Read More

News

Inhaled vasodilator type has no impact on outcomes

Author:
Heidi Splete
Publish date: September 15, 2022

Successful extubations were similar for patients on inhaled vasodilators using nitric oxide and epoprostenol in a comparison study.

  • Read More

News

Congenital cytomegalovirus declined in wake of COVID-19

Author:
Heidi Splete
Publish date: September 13, 2022

Racial disparities remained but were lower in the pandemic period, compared with previous prepandemic studies.

  • Read More

News

FDA approves oral TYK2 inhibitor deucravacitinib for treating psoriasis

Author:
Heidi Splete
Publish date: September 12, 2022

Approval was based on the results of two phase 3 trials of almost 1,700 adults with moderate to severe plaque psoriasis.

  • Read More

News

Baseline neuromotor abnormalities persist in schizophrenia

Author:
Heidi Splete
Publish date: September 9, 2022

Long-term follow-up data showed predictive value of dyskinesia and neurological soft signs for neuromotor dysfunction.

  • Read More

News

Isotretinoin prescribers need better education on emergency contraception

Author:
Heidi Splete
Publish date: September 9, 2022

Two-thirds of providers reported receiving no education on emergency contraception, despite relevance to isotretinoin patients.

  • Read More

News

New study supports safety of COVID-19 boosters during pregnancy

Author:
Heidi Splete
Publish date: September 9, 2022

Local and systemic reactions, such as aches and pains, from a COVID-19 booster or third dose were short-lived with no ongoing concerns in pregnant...

  • Read More

Pages

  • « first
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close